CN Patent

CN102414185A — [4-(2-氯-4-甲氧基-5-甲基苯基)-5-甲基-噻唑-2-基]-[2-环丙基-1-(3-氟-4-甲基苯基)-乙基]-胺的制备方法

Assigned to Sanofi Aventis France · Expires 2012-04-11 · 14y expired

What this patent protects

本发明的主题是式(I)的[4-(2-氯-4-甲氧基-5-甲基苯基)-5-甲基-噻唑-2-基]-[2-环丙基-1-(3-氟-4-甲基苯基)-乙基]-胺的新制备方法，以及所述制备方法的新的中间体。

USPTO Abstract

本发明的主题是式(I)的[4-(2-氯-4-甲氧基-5-甲基苯基)-5-甲基-噻唑-2-基]-[2-环丙基-1-(3-氟-4-甲基苯基)-乙基]-胺的新制备方法，以及所述制备方法的新的中间体。

Drugs covered by this patent

Patent Metadata

Patent number
CN102414185A
Jurisdiction
CN
Classification
—
Expires
2012-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis France
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.